Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$96.99
+1.33%
Mkt Cap $19.15B
Analyst Ratings
Buy
15
Hold
6
Sell
0
Price Target (48 analysts)
$108.90
Range $84.00 – $135.00
Implied Upside
+12.3%
Consensus $108.90 vs current $96.99
NASDAQ·Healthcare·Biotechnology
$96.99
+1.33%
Mkt Cap $19.15B
Buy
15
Hold
6
Sell
0
Price Target (48 analysts)
$108.90
Range $84.00 – $135.00
+12.3%
Consensus $108.90 vs current $96.99